Concepedia

Author

Guizhen Dong

Ligand Pharmaceuticals (United States)

Also Known As

Guizhen Dong

8

Publications

186

Citations

7

H-Index

16

Concepts

All Affiliations

Ligand Pharmaceuticals (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)
GD

About

Guizhen Dong is an author at Ligand Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

172

2

Biochemistry

3

3

77

3

Natural Sciences

2

2

60

4

Biomolecular Engineering

1

1

46

5

Chemistry

1

1

23

Guizhen Dong

×

6

Publications

172

Citations

6

H-Index

YearCitations

Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis

Tao Guo, Anton E.P. Adang, Guizhen Dong,

Bioorganic & Medicinal Chemistry Letters

2004

46

Small molecule biaryl FSH receptor agonists. Part 1

Tao Guo, Anton E.P. Adang, Roland E. Dolle,

Bioorganic & Medicinal Chemistry Letters

2004

45

Novel CXCR3 antagonists with a piperazinyl-piperidine core

Brian McGuinness, Carolyn DiIanni Carroll, Lisa Guise Zawacki,

Bioorganic & Medicinal Chemistry Letters

2009

26

II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists

Yuefei Shao, G. Anilkumar, Carolyn DiIanni Carroll,

Bioorganic & Medicinal Chemistry Letters

2010

23

III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold

Seong Heon Kim, G. Anilkumar, Lisa Guise Zawacki,

Bioorganic & Medicinal Chemistry Letters

2011

17

2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors

Koc-Kan Ho, Kenneth C. Appell, John J. Baldwin,

Bioorganic & Medicinal Chemistry Letters

2003

15

Page 1